Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation, other
Remarks:
repeated painting of guinea pig skin
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Qualifier:
no guideline followed
Version / remarks:
repeated painting of guinea pig skin
Principles of method if other than guideline:
No methods have been provided in the literature
GLP compliance:
not specified
Type of study:
not specified
Justification for non-LLNA method:
No methods have been provided in the literature
Species:
guinea pig
Remarks on result:
positive indication of skin sensitisation

The repeated painting of guinea pig skin over an 11-day period with 0.1, 0.5 and 1 % solutions of 1,4 -naphthoquinone in ether on days 1 to 2,3 to 4 and 6 to 11, respectively, caused reddening of the skin at the beginning of the treatment with subsequent brown-blaek scab formation. After the local effects had healed up (by day 21). a 0.1 % solution (which had been shown to cause only minimal irritation after a single application) was applied on day 23 to part of the skin that had not previously been treated; this led to local allergic reactions of the skin (reddening, oedema and nodule formation) in all of the animals, which diminished after 24 hours with mild peeling.

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Conclusions:
Based on this study, 1,4 -naphthoquinone was considered to be a skin sensitiser.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)

Justification for classification or non-classification